about
Psychiatric comorbidities and schizophreniaPsychosocial correlates with depressive symptoms six years after a first episode of psychosis as compared with findings from a general population sampleAntidepressive effects of traditional and second generation antipsychotics: a review of the clinical data.Negative symptoms: psychopathological modelsAssessment of anti-psychotic drugs.Influence of novel and conventional antipsychotic medication on subjective quality of lifeManaging suicide risk in patients with schizophreniaHow effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials.Differential diagnosis of depressed mood in patients with schizophrenia: a diagnostic algorithm based on a review.Postpsychotic depression in schizophrenia patients.Co-occurring depressive symptoms in the older patient with schizophrenia.The relationships between depression and remission in first-episode psychosisTrial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical and social outcome at two years.Suicidal behavior in the older patient with schizophrenia.Management of the schizophrenic patient.Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year.Neuroleptic dysphoria: revisiting the concept 50 years later.Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms?Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations.Subdomains within the negative symptoms of schizophrenia: commentary.The impact of subjective well-being under neuroleptic treatment on compliance and remission.Symptom domains of schizophrenia: the role of atypical antipsychotic agents.Lack of insight in schizophrenia: impact on treatment adherence.Emotional processing in schizophrenia.Does self-perceived mood predict more variance in cognitive performance than clinician-rated symptoms in schizophrenia?Subjective well-being in schizophrenia as measured with the Subjective Well-Being under Neuroleptic Treatment scale: a review.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactatioAntipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy.[Who are the patients treated in an outpatient clinic with high dosage neuroleptics?]Depressive syndromes in schizophrenic patients after discharge from hospital. ANI Study Group Berlin, Düsseldorf, Göttingen, Munich.The relationship of negative schizophrenia to parkinsonism.Positive and negative syndromes in schizophrenia as a function of chronicity.Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia.Is negative schizophrenia a variant of parkinsonism?[New insights into the pathogenesis and pathophysiology of depression].Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale.The time structure of depressive mood in schizophrenic patients.Extrapyramidal symptoms and residual psychopathology with low-dose neuroleptics.A comprehensive treatment program for schizophrenia and chronic mental illness.
P2860
Q22242829-0C5ED7E2-D6AF-4737-88B0-A00B8ADD7616Q24807243-8E8E18C2-F124-48CC-A6BB-3E53700D80B3Q30986546-7C2368F9-BC81-4F8C-8B07-E37147877B5EQ33920833-FDEB0448-49A1-4B8F-A08C-D22FF2012372Q34448621-FB8CF12B-A344-4781-96DE-4A28F684BFD0Q34464310-13A7B4BD-0A00-4125-B62B-4DF403BC80E6Q34664040-E0827616-1313-480F-A61A-A5531E934340Q34733976-98AA01E0-C967-485B-94B5-E2E486EA106EQ34744036-727395F3-93E4-4333-BDF2-3515AF071EDBQ34749196-2BF3529C-D8F6-42CD-B2DF-FE3662C3BDF3Q35008098-0333093F-BBFF-4E45-BE18-3CD9622CC361Q35129876-70934996-F1F5-4397-B2BD-2528415B1B3BQ35170910-7FF9FDB0-FF0E-4D0F-9D75-4D35D644BEFCQ35414138-930806A0-EEF9-4F70-AF26-D33645446F7BQ35674707-2BA9D1C4-8A58-4DF3-81B5-1A630553B1FBQ35711005-B287A1D4-A2A6-4328-8FAB-7E790609D111Q36118562-450DDCAB-D523-468C-BB02-84FB280865F4Q36183110-17A50833-F73F-43C7-BDC1-C52A701CD4CDQ36183115-DBD6B882-096D-43FF-B192-921E2A9E6D53Q36403000-E37EA8BB-2870-47D0-B7A4-2BAB6D867068Q36460707-8CB9C45C-BE0D-4B97-975F-BCE395D7CACCQ36626242-03016F28-BDB8-4C1A-BEDC-59384991944FQ36729616-0425C5D8-A38D-40BB-B925-B760B6A7B8F0Q36758406-3C5205D7-4DB9-4A31-B35F-FD77DF306B09Q37075965-6B4B2918-8B0E-4254-846A-24B5D6846B28Q37857856-3B09241F-EE68-47B2-9B79-347FC09EB2CAQ38395937-0E95B9F3-4B10-42DE-A473-BDB79CC37139Q39396657-A977DF79-CE83-4734-AB9B-AFCD50D33F0CQ41173472-C75EFB9E-6EEB-4921-9759-320BE560DF72Q41176006-798A4BF1-CBCA-4FE9-8ADE-902A744C1E21Q41178359-533068CF-E526-4AF2-AADA-E671AA948D52Q41346456-0F11CEDE-455B-4197-A229-9C4DC9F6C352Q43431058-E34C1185-3D97-4690-9D8F-C682AA3B33ABQ44518148-0A2D0194-F120-4167-B923-BE602518E01CQ44540621-3DDC4919-77A2-4FF8-B003-65D5A33ECFF0Q46932234-2540C473-7B01-4A03-96DA-10C81F73D326Q48975165-57BBAB05-D324-42F1-8245-90111A6B5DE7Q51250968-0ECA4F07-0DB8-45DF-9207-25F48FA0D3C0Q51952586-4529A0ED-C4E1-4518-AF2C-0E5F34C8DDF9Q52081045-819C6D9A-B5BB-42FB-84A1-E41F4EA2AE08
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
"Akinetic depression" in schizophrenia.
@en
"Akinetic depression" in schizophrenia.
@nl
type
label
"Akinetic depression" in schizophrenia.
@en
"Akinetic depression" in schizophrenia.
@nl
prefLabel
"Akinetic depression" in schizophrenia.
@en
"Akinetic depression" in schizophrenia.
@nl
P1433
P1476
"Akinetic depression" in schizophrenia.
@en
P2093
P304
P356
10.1001/ARCHPSYC.1978.01770330075006
P407
P577
1978-09-01T00:00:00Z